Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Long-acting VEGF inhibitors for intraocular neovascularization

Long-acting VEGF inhibitors for intraocular neovascularization

US Patent 11433118 · Granted Sep 6, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Long-acting VEGF inhibitors for intraocular neovascularization2023
Methods and compositions for treatment of angiogenic disorders using anti-VEGF a2022
Long-acting VEGF inhibitors for intraocular neovascularization2022
Methods of inhibiting vascular endothelial growth factor activity2016
Anti-Bv8 antibodies and uses thereof2016
Compositions with hematopoietic and immune activity2014
Anti-BV8 antibodies and uses thereof2014
Inhibitors of angiopoietin-like 4 protein, combinations, and their use2013
EG-VEGF nucleic acids and polypeptides and methods of use2013
Composition comprising and method of using angiopoietin-like protein 3 ANGPTL32013
Vascular endothelial cell growth factor antagonists and uses thereof2012
Inhibitors of vascular endothelial growth factor activity2012